|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Innate Pharma (NASDAQ: IPHA) through any online brokerage.
The latest price target for Innate Pharma (NASDAQ: IPHA) was reported by SVB Leerink on September 17, 2021. The analyst firm set a price target for 9.00 expecting IPHA to rise to within 12 months (a possible 70.45% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Innate Pharma (NASDAQ: IPHA) is $5.28 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Innate Pharma.
Innate Pharma’s $H1 earnings are confirmed for after-market on $September 15, 2021.
There is no upcoming split for Innate Pharma.
Innate Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.